Summer is for science! PNNL’s interns are diving into science and technology and getting a front-row view of the research and development of a national laboratory.

The Rapid Assessment of Platform Technologies to Expedite Response project aims to prepare against future pandemics.

Two researchers at PNNL have been named fellows of the American Chemical Society: Karthikeyan Ramasamy and Yuyan Shao.

PNNL’s wide-ranging report maps the current nanobiotechnology landscape, flags potential concerns, and details the need for an organizing body to coordinate currently disparate disciplines.

Scientists have taken an important step forward in predicting who will develop Type 1 diabetes months before symptoms appear.

Lauren Charles, a chief data scientist at PNNL, joined the editorial board of the largest open access journal published by Nature Research.

Joshua Adkins and Jamie Lo will lead PMedIC, Pacific Northwest National Laboratory and Oregon Health & Science University’s joint research institute.

DOE gives Hydrogen Program Special Award to PNNL's Hydrogen Safety Panel at department's 2023 Annual Merit Review and Peer Evaluation Meeting.

PNNL scientists investigate the promising properties of a common, Earth-abundant salt.

COVID-19 infections at PNNL early in the pandemic were caused by a wide variety of viral sequences, according to a new analysis by Laboratory researchers.

PNNL hydrogen expert Olga Marina has been named among the pioneering women in applied physics in a roadmap published in Journal of Physics D.

Patented microchannel heat-exchange technology enables the production of hydrogen from methane, the main ingredient of natural gas, while producing 30 percent less carbon dioxide than conventional processes.

Gosline works to develop computational algorithms that are uniquely targeted for rare disease work by doing foundational research in model system development. This work can be expanded to all model systems in human disease.

PNNL is working with the Port of Seattle and Seattle City Light to assess the risks of long-term hydrogen storage that can bring clean power for decarbonization.

Exploring why some brains are more resilient to the impact of Alzheimer’s disease could lead to improved diagnoses, treatment and prevention.

Advanced proteomic analysis tools dig deep into human blood plasma to understand the molecular nature of advanced alcoholic disease.

A detailed snapshot of proteins by PNNL scientists marks a big step toward a diagnostic blood test for a deadly form of liver disease.

A paper by PNNL researchers has been chosen as one of 32 NIEHS Papers of the Year—a top 1% honor in the research field.

Harnessing the sea for decarbonized energy is the focus of a new collaboration between PNNL and the University of Guam.

PNNL Biomedical Scientist Geremy Clair has taken on new roles as an editor for two journals; Frontiers In Cellular And Infection Microbiology and Frontiers In Molecular Biosciences.